Literature DB >> 21494015

Sleep disorders in spinocerebellar ataxia type 2 patients.

Luis Velázquez-Pérez1, Ursula Voss, Roberto Rodríguez-Labrada, Georg Auburger, Nalia Canales Ochoa, Gilberto Sánchez Cruz, Lourdes Galicia Polo, Reyes Haro Valencia, Raúl Aguilera Rodríguez, Jacqueline Medrano Montero, Jose M Laffita Mesa, Inka Tuin.   

Abstract

BACKGROUND: Sleep disturbances are common features in spinocerebellar ataxias (SCAs). Nevertheless, sleep data on SCA2 come from scarce studies including few patients, limiting the evaluation of the prevalence and determinants of sleep disorders.
OBJECTIVE: To assess the frequency and possible determinants of sleep disorders in the large and homogeneous SCA2 Cuban population.
METHODS: Thirty-two SCA2 patients and their age- and sex-matched controls were studied by video-polysomnography and sleep interviews.
RESULTS: The most striking video-polysomnography features were rapid eye movement (REM) sleep pathology and periodic leg movements (PLMs). REM sleep abnormalities included a consistent reduction of the REM sleep percentage and REM density as well as an increase in REM sleep without atonia (RWA). REM sleep and REM density decreases were closely related to the increase in ataxia scores, whereas the RWA percentage was influenced by the cytosine-adenine-guanine (CAG) repeats. PLMs were observed in 37.5% of cases. The PLM index showed a significant association with the ataxia score and disease duration but not with CAG repeats.
CONCLUSIONS: REM sleep pathology and PLMs are closely related to SCA2 severity, suggesting their usefulness as disease progression markers. The RWA percentage is influenced by the CAG repeats and might thus be a sensitive parameter for reflecting polyglutamine toxicity. Finally, as PLMs are sensible to drug treatment, they represents a new therapeutic target for the symptomatic treatment of SCA2.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21494015     DOI: 10.1159/000324374

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  18 in total

1.  Lisuride reduces involuntary periodic leg movements in spinocerebellar ataxia type 2 patients.

Authors:  Luis Velázquez-Pérez; Roberto Rodríguez-Labrada; Lázaro Álvarez-González; Raúl Aguilera-Rodríguez; Mario Álvarez Sánchez; Nalia Canales-Ochoa; Lourdes Galicia Polo; Reyes Haro-Valencia; Jacqueline Medrano-Montero; Yaimeé Vázquez-Mojena; Arnoy Peña-Acosta; Annelié Estupiñán-Rodríguez; Noemí Rodríguez Pupo
Journal:  Cerebellum       Date:  2012-12       Impact factor: 3.847

2.  Abnormal Findings in Polysomnographic Recordings of Patients with Spinocerebellar Ataxia Type 2 (SCA2).

Authors:  Alessandra Zanatta; Carlos Henrique Ferreira Camargo; Francisco Manoel Branco Germiniani; Salmo Raskin; Ana Chrystina de Souza Crippa; Hélio Afonso Ghizoni Teive
Journal:  Cerebellum       Date:  2019-04       Impact factor: 3.847

Review 3.  Spinocerebellar ataxias: prospects and challenges for therapy development.

Authors:  Tetsuo Ashizawa; Gülin Öz; Henry L Paulson
Journal:  Nat Rev Neurol       Date:  2018-10       Impact factor: 42.937

4.  Spectrum of sleep disorders in a patient with spinocerebellar ataxia 13.

Authors:  Mukesh Kapoor; Glen Greenough
Journal:  J Clin Sleep Med       Date:  2015-01-15       Impact factor: 4.062

5.  Antimony and sleep-related disorders: NHANES 2005-2008.

Authors:  Franco Scinicariello; Melanie C Buser; Aliya G Feroe; Roberta Attanasio
Journal:  Environ Res       Date:  2017-03-28       Impact factor: 6.498

Review 6.  Sleep Disorders in Hereditary Ataxias.

Authors:  Lucio Huebra; Fernando Morgadinho Coelho; Flávio Moura Rezende Filho; Orlando G Barsottini; José Luiz Pedroso
Journal:  Curr Neurol Neurosci Rep       Date:  2019-07-25       Impact factor: 5.081

Review 7.  Molecular Mechanisms and Therapeutics for Spinocerebellar Ataxia Type 2.

Authors:  Polina A Egorova; Ilya B Bezprozvanny
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

8.  Dream enactment behavior: review for the clinician.

Authors:  Marc Baltzan; Chun Yao; Dorrie Rizzo; Ron Postuma
Journal:  J Clin Sleep Med       Date:  2020-11-15       Impact factor: 4.062

9.  A role for Drosophila ATX2 in activation of PER translation and circadian behavior.

Authors:  Yong Zhang; Jinli Ling; Chunyan Yuan; Raphaëlle Dubruille; Patrick Emery
Journal:  Science       Date:  2013-05-17       Impact factor: 47.728

10.  Non-motor and Extracerebellar Features in Spinocerebellar Ataxia Type 2.

Authors:  José Luiz Pedroso; Pedro Braga-Neto; Marcio Luiz Escorcio-Bezerra; Agessandro Abrahão; Marcus Vinicius Cristino de Albuquerque; Flavio Moura Rezende Filho; Paulo Victor Sgobbi de Souza; Wladimir Bocca Vieira de Rezende Pinto; Franklin Roberto Pereira Borges; Maria Luiza Saraiva-Pereira; Laura Bannach Jardim; Orlando G P Barsottini
Journal:  Cerebellum       Date:  2017-02       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.